WHOM the hell is going to start testing this in humans?
Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats
- a Department of Neurosurgery, 2799W Grand Blvd, Henry Ford Hospital, Detroit, MI, 48202 USA
- b Department of Neurology, 2799W Grand Blvd, Henry Ford Hospital, Detroit, MI, 48202 USA
- c Department of Physics, Oakland University, 2200 North Squirrel Road, Rochester, MI, 48309-4401 USA
- d Department of Biomedical Engineering, Science and Technology Center, Room 251, Tufts University, Boston, MA, 02155 USA
Choose an option to locate/access this article:
Check if you have access through your login credentials or your institution
Check accessHighlights
- •
- Human bone marrow stromal cells were impregnated into scaffolds for transplantation.
- •
- Scaffold+hMSC treatment reduced Nogo-A protein level in the injured brain.
- •
- Scaffold+hMSC treatment down-regulated Nogo-A gene transcription in oligodendrocytes.
- •
- Scaffold+hMSC treatment increased axonal density after TBI.
Abstract
Nogo-A
is a major form of growth inhibitory molecule (growth-IM) which
inhibits axonal regeneration and neurite regrowth after neural injury.
Bone marrow stromal cells (MSCs) have been shown to inhibit Nogo-A
expression in vitro and in cerebral ischemic animal models. The
present study was designed to investigate the effects of treatment with
human MSCs (hMSCs) impregnated into collagen scaffolds on the
expression of Nogo-A and axonal plasticity after traumatic brain injury
(TBI). Adult male Wistar rats were injured with controlled cortical
impact and treated either with saline, hMSCs-alone or hMSCs impregnated
into collagen scaffolds (scaffold+hMSC) transplanted into the lesion
cavity 7 days after TBI. Rats were sacrificed 14 days after TBI and
brain tissues were harvested for immunohistochemical studies, Western
blot analysis, laser capture microdissections and qRT-PCR to evaluate
axonal density and Nogo-A protein and gene expressions. Our data showed
that treatment of TBI with scaffold+hMSC significantly decreased
TBI-induced Nogo-A protein expression and increased axonal density
compared to saline and hMSC-alone treatments. In addition, scaffold+hMSC
transplantation decreased Nogo-A transcription in oligodendrocytes
after TBI. Scaffold +hMSC treatment was superior to hMSC-alone treatment
in suppressing Nogo-A expression and enhancing axonal regeneration
after TBI. Our data suggest that transplanting hMSCs with scaffolds
down-regulates Nogo-A transcription and protein expression which may
partially contribute to the enhanced axonal regeneration after TBI.
No comments:
Post a Comment